AUSTIN, Texas, April 28, 2011 /PRNewswire/ --
Q1 2011 Highlights
- Revenue of $238 million, up 24 percent year-over-year
- Record revenue for a first quarter in software, data acquisition, PXI and NI CompactRIO products
- Record GAAP gross margin of 77.9 percent and non-GAAP gross margin of 78.5 percent
- Record GAAP and non-GAAP operating income for a first quarter
- Fully diluted GAAP EPS of $0.25
- Fully diluted non-GAAP EPS of $0.28
- Record EBITDA of $47.7 million, or $0.40 per share for a first quarter
- Cash and short-term investments of $385 million as of March 31, 2011
National Instruments (Nasdaq: NATI) today announced Q1 revenue of $238 million, a new first quarter record and a 24 percent increase from Q1 2010. This met the company's guidance of between $230 million and $244 million, which was provided on Jan. 25, 2011. In Q1, the company's orders greater than $20,000 grew 29 percent year-over-year, and the average order size reached a new first quarter record of approximately $4,000.
In Q1, GAAP and non-GAAP operating income reached all-time records for a first quarter, and non-GAAP operating margins were the highest for a first quarter since 2001. Net income for Q1 was $30.5 million, with fully diluted earnings per share (EPS) of $0.25, and non-GAAP net income was $33.9 million, with non-GAAP fully diluted EPS of $0.28. EBITDA, or Earnings Before Interest, Taxes, Depreciation and Amortization, was also a new Q1 record at $47.7 million, or $0.40 per share.
In Q1, GAAP gross margin increased 50 basis points year-over-year to 77.9 percent. Non-GAAP gross margin reached an all-time record of 78.5 percent, an increase of 60 basis points year-over-year.
The company's non-GAAP results exclude the impact of both stock-based compensation and the amortization of acquisition-related intangibles. Reconciliations of the company's GAAP and non-GAAP results are included as part of this news release.
"I was extremely pleased with our performance in Q1 as we delivered record revenue and profit for a first quarter, and I would like to thank all of our employees for the hard work they have contributed to this very strong result," said Dr. James Truchard, co-founder, president and CEO. "Our core platforms of LabVIEW, DAQ, PXI and CompactRIO drove our growth this quarter, and we believe that our commitment to innovation and growing relationships with our customers will continue to drive growth in these strategic platforms."
NI graphical system design product sales were up 25 percent year-over-year. NI instrument control product sales were up 18 percent year-over-year in Q1. During Q1, deferred revenue increased by $6 million, which is double the amount in Q1 last year, and backlog declined by $7 million.
Geographically, revenue in U.S. dollar terms for Q1 2011 compared to Q1 2010 was up 23 percent in the Americas, up 23 percent in Europe and up 29 percent in Asia. In local currency terms, revenue was up 26 percent in Europe and up 29 percent in Asia.
As of March 31, NI had $385 million in cash and short-term investments. The National Instruments Board of Directors approved a quarterly dividend of $0.10 per share on the company's common stock payable on May 31 to stockholders of record on May 9.
Guidance for Q2 2011
While the trends of the global Purchasing Managers Index (PMI) continued to be positive in Q1, the impact of the earthquake and tsunami that struck Japan, the spike in oil prices and U.S. federal budget issues all impacted global business conditions, especially in the automotive sector. These macroeconomic events have made the company incrementally more cautious regarding Q2.
"While we are pleased to see greater than 20 percent year-over-year order growth in April, we do see some reasons for caution as we look out to the rest of Q2," said Alex Davern, NI COO and CFO. "However, we are confident in our long-term opportunity and are successfully executing on our plan to aggressively increase our R&D and field sales personnel in 2011."
NI expects revenue for Q2 to be between $241 million and $255 million, an increase of between 14 and 20 percent over Q2 2010. The company expects fully diluted EPS will be in the range of $0.19 to $0.27 for Q1, with non-GAAP fully diluted EPS expected to be in the range of $0.23 to $0.31.
Non-GAAP Presentation
In addition to disclosing results determined in accordance with GAAP, NI discloses certain non-GAAP operating results and non-GAAP information that exclude certain charges. In this news release, the company has presented its gross profit, operating expenses, operating income, income before income taxes, provision for income taxes, net income and basic and fully diluted EPS for the three-month periods ending March 31, 2011 and 2010, on a GAAP and non-GAAP basis. When presenting non-GAAP information, the company includes a reconciliation of the non-GAAP results to the GAAP results. Management believes that including the non-GAAP results assists investors in assessing the company's operational performance and its performance relative to its competitors. The company presents these non-GAAP results as a complement to results provided in accordance with GAAP, and these results should not be regarded as a substitute for GAAP. Management uses these non-GAAP measures to manage and assess the profitability and performance of its business and does not consider stock-based compensation expense or amortization of acquired intangibles that are non-cash charges in managing its operations. Specifically, management uses non-GAAP measures to plan and forecast future periods, to establish operational goals, to compare with its business plan and individual operating budgets, to measure management performance for the purposes of executive compensation including payments to be made under bonus plans, to assist the public in measuring the company's performance relative to the company's long-term public performance goals, to allocate resources and, relative to the company's historical financial performance, to enable comparability between periods. Management also considers such non-GAAP results to be an important supplemental measure of its performance. This news release also discloses the company's earnings before interest, taxes, depreciation and amortization (EBITDA) and EBITDA diluted EPS for the three-month periods ended March 31, 2011 and 2010. The company also believes that including the EBITDA results assists investors in assessing the company's operational performance relative to its competitors. A reconciliation of EBITDA and EBITDA diluted EPS to GAAP net income and GAAP diluted EPS is included with this news release.
Conference Call Information
Interested parties can listen to the Q1 2011 conference call today, April 28, beginning at 4:00 p.m. CDT, at www.ni.com/call. Replay information is available by calling (888) 203-1112, confirmation code #8955082, shortly after the call through May 3 at 7:00 p.m. CDT.
Forward-Looking Statements
This release contains "forward-looking statements," including statements related to continuing to drive growth in strategic platforms, being confident in our long-term opportunity, plans to aggressively increase our R&D and field sales personnel in 2011 and our Q2 guidance for revenue and GAAP and non-GAAP EPS. These statements are subject to a number of risks and uncertainties, including the risk of adverse changes or fluctuations in the global economy, component shortages, delays in the release of new products, fluctuations in customer demand for NI products, the company's ability to continue to control its operating expenses, manufacturing inefficiencies, the outcome of events in Japan and foreign exchange fluctuations. Actual results may differ materially from the expected results. The company directs readers to its Form 10-K for the fiscal year ended Dec. 31, 2010, its Form 10-Q for the quarter ended March 31, 2011, and the other documents it files with the SEC for other risks associated with the company's future performance.
About National Instruments
National Instruments (www.ni.com) is transforming the way engineers and scientists design, prototype and deploy systems for measurement, automation and embedded applications. NI empowers customers with off-the-shelf software such as NI LabVIEW and modular cost-effective hardware, and sells to a broad base of more than 30,000 different companies worldwide, with its largest customer representing approximately 4 percent of revenue in 2010 and no one industry representing more than 15 percent of revenue. Headquartered in Austin, Texas, NI has approximately 5,500 employees and direct operations in more than 40 countries. For the past 12 years, FORTUNE magazine has named NI one of the 100 best companies to work for in America. Readers can obtain investment information from the company's investor relations department by calling (512) 683-5090, e-mailing [email protected] or visiting www.ni.com/nati. (NATI-F)
CompactRIO, LabVIEW, National Instruments, NI and ni.com are trademarks of National Instruments. Other product and company names listed are trademarks or trade names of their respective companies.
Contact: |
Veronica Garza |
|
Investor Relations |
||
(512) 683-6873 |
||
National Instruments |
|||||
Consolidated Balance Sheets |
|||||
(in thousands) |
|||||
March 31, |
December 31, |
||||
2011 |
2010 |
||||
(unaudited) |
|||||
Assets |
|||||
Current assets: |
|||||
Cash and cash equivalents |
$ |
254,594 |
$ |
219,447 |
|
Short-term investments |
130,460 |
131,215 |
|||
Accounts receivable, net |
132,148 |
127,214 |
|||
Inventories, net |
134,408 |
117,765 |
|||
Prepaid expenses and other current assets |
25,459 |
36,239 |
|||
Deferred income taxes, net |
19,792 |
18,838 |
|||
Total current assets |
696,861 |
650,718 |
|||
Property and equipment, net |
164,288 |
160,410 |
|||
Goodwill |
70,768 |
70,278 |
|||
Intangible assets, net |
51,928 |
52,816 |
|||
Other long-term assets |
27,584 |
25,460 |
|||
Total assets |
$ |
1,011,429 |
$ |
959,682 |
|
Liabilities and Stockholders' Equity |
|||||
Current liabilities: |
|||||
Accounts payable |
$ |
36,615 |
$ |
33,544 |
|
Accrued compensation |
22,952 |
27,734 |
|||
Deferred revenue |
77,787 |
71,650 |
|||
Accrued expenses and other liabilities |
14,081 |
16,538 |
|||
Other taxes payable |
14,805 |
16,846 |
|||
Total current liabilities |
166,240 |
166,312 |
|||
Deferred income taxes |
29,697 |
29,477 |
|||
Liability for uncertain tax positions |
16,416 |
14,953 |
|||
Other long-term liabilities |
4,694 |
4,395 |
|||
Total liabilities |
$ |
217,047 |
$ |
215,137 |
|
Stockholders' equity: |
|||||
Preferred stock |
- |
- |
|||
Common stock |
1,190 |
786 |
|||
Additional paid-in capital |
431,726 |
408,106 |
|||
Retained earnings |
354,956 |
336,363 |
|||
Accumulated other comprehensive income (loss) |
6,510 |
(710) |
|||
Total stockholders' equity |
$ |
794,382 |
$ |
744,545 |
|
Total liabilities and stockholders' equity |
$ |
1,011,429 |
$ |
959,682 |
|
National Instruments |
|||||
Consolidated Statements of Income |
|||||
(in thousands, except per share data) |
|||||
Three Months Ended |
|||||
March 31, |
|||||
(unaudited) |
|||||
2011 |
2010 |
||||
Net sales: |
|||||
Product |
$ |
218,610 |
$ |
175,395 |
|
Software maintenance |
19,240 |
15,696 |
|||
Total net sales |
237,850 |
191,091 |
|||
Cost of sales: |
|||||
Cost of product |
$ |
50,958 |
$ |
42,262 |
|
Cost of software maintenance |
1,518 |
980 |
|||
Total cost of sales |
52,476 |
43,242 |
|||
Gross profit |
$ |
185,374 |
$ |
147,849 |
|
Operating expenses: |
|||||
Sales and marketing |
$ |
87,155 |
$ |
74,441 |
|
Research and development |
42,868 |
38,546 |
|||
General and administrative |
18,839 |
15,340 |
|||
Total operating expenses |
$ |
148,862 |
$ |
128,327 |
|
Operating income |
$ |
36,512 |
$ |
19,522 |
|
Other income (expense): |
|||||
Interest income |
$ |
341 |
$ |
300 |
|
Net foreign exchange (loss) |
(223) |
(698) |
|||
Other income, net |
446 |
348 |
|||
Income before income taxes |
$ |
37,076 |
$ |
19,472 |
|
Provision for income taxes |
6,615 |
1,119 |
|||
Net income |
$ |
30,461 |
$ |
18,353 |
|
Basic earnings per share |
$ |
0.26 |
$ |
0.16 |
|
Diluted earnings per share |
$ |
0.25 |
$ |
0.16 |
|
Weighted average shares outstanding - |
|||||
Basic |
118,693 |
116,070 |
|||
Diluted |
120,443 |
117,652 |
|||
Dividends declared per share |
$ |
0.10 |
$ |
0.09 |
|
National Instruments |
|||||
Consolidated Statements of Cash Flows |
|||||
(in thousands) |
|||||
Three Months Ended |
|||||
March 31, |
|||||
(unaudited) |
|||||
2011 |
2010 |
||||
Cash flow from operating activities: |
|||||
Net income |
$ |
30,461 |
$ |
18,353 |
|
Adjustments to reconcile net income to net cash provided |
|||||
by operating activities: |
|||||
Depreciation and amortization |
10,973 |
9,442 |
|||
Stock-based compensation |
4,590 |
4,916 |
|||
Tax expense (benefit) from deferred income taxes |
(560) |
1,709 |
|||
Tax expense (benefit) from stock option plans |
(1,327) |
1,587 |
|||
Changes in operating assets and liabilities: |
|||||
Accounts receivable |
(4,933) |
(613) |
|||
Inventories |
(16,643) |
(3,006) |
|||
Prepaid expenses and other assets |
14,995 |
(297) |
|||
Accounts payable |
3,071 |
3,618 |
|||
Deferred revenue |
6,137 |
3,730 |
|||
Taxes and other liabilities |
(5,134) |
2,162 |
|||
Net cash provided by operating activities |
$ |
41,630 |
$ |
41,601 |
|
Cash flow from investing activities: |
|||||
Capital expenditures |
(9,580) |
(5,271) |
|||
Capitalization of internally developed software |
(3,731) |
(3,404) |
|||
Additions to other intangibles |
(436) |
(543) |
|||
Acquisition, net of cash received |
- |
(2,191) |
|||
Purchases of short-term investments |
(27,176) |
(35,823) |
|||
Sales and maturities of short-term investments |
27,931 |
9,037 |
|||
Net cash (used by) investing activities |
$ |
(12,992) |
$ |
(38,195) |
|
Cash flow from financing activities: |
|||||
Proceeds from issuance of common stock |
17,050 |
22,341 |
|||
Repurchase of common stock |
- |
(30,935) |
|||
Dividends paid |
(11,868) |
(10,072) |
|||
Tax (expense) benefit from stock option plans |
1,327 |
(1,587) |
|||
Net cash provided (used) by financing activities |
$ |
6,509 |
$ |
(20,253) |
|
Net change in cash and cash equivalents |
35,147 |
(16,847) |
|||
Cash and cash equivalents at beginning of period |
219,447 |
201,465 |
|||
Cash and cash equivalents at end of period |
$ |
254,594 |
$ |
184,618 |
|
Detail of GAAP charges related to stock-based compensation and |
|||||
amortization of acquisition intangibles |
|||||
(unaudited) |
|||||
Three Months Ended |
|||||
March 31, |
|||||
2011 |
2010 |
||||
Stock-based compensation |
|||||
Cost of sales |
$ |
317 |
$ |
362 |
|
Sales and marketing |
1,922 |
2,104 |
|||
Research and development |
1,686 |
1,765 |
|||
General and administrative |
665 |
685 |
|||
Provision for income taxes |
(1,840) |
(1,545) |
|||
Total |
$ |
2,750 |
$ |
3,371 |
|
Amortization of acquisition intangibles |
|||||
Cost of sales |
$ |
1,004 |
$ |
722 |
|
Sales and marketing |
77 |
122 |
|||
Research and development |
- |
- |
|||
General and administrative |
- |
- |
|||
Provision for income taxes |
(350) |
(253) |
|||
Total |
$ |
731 |
$ |
591 |
|
National Instruments |
|||||
Reconciliation of GAAP to Non-GAAP Measures |
|||||
(in thousands, except per share data) |
|||||
(unaudited) |
|||||
Three Months Ended |
|||||
March 31, |
|||||
2011 |
2010 |
||||
Reconciliation of Gross Profit to Non-GAAP Gross Profit |
|||||
Gross profit, as reported |
$ |
185,374 |
$ |
147,849 |
|
Stock-based compensation |
317 |
362 |
|||
Amortization of acquisition intangibles |
1,004 |
722 |
|||
Non-GAAP gross profit |
$ |
186,695 |
$ |
148,933 |
|
Reconciliation of Operating Expenses to Non-GAAP Operating Expenses |
|||||
Operating expenses, as reported |
$ |
148,862 |
$ |
128,327 |
|
Stock-based compensation |
(4,273) |
(4,554) |
|||
Amortization of acquisition intangibles |
(77) |
(122) |
|||
Non-GAAP operating expenses |
$ |
144,512 |
$ |
123,651 |
|
Reconciliation of Operating Income to Non-GAAP Operating Income |
|||||
Operating income, as reported |
$ |
36,512 |
$ |
19,522 |
|
Stock-based compensation |
4,590 |
4,916 |
|||
Amortization of acquisition intangibles |
1,081 |
844 |
|||
Non-GAAP operating income |
$ |
42,183 |
$ |
25,282 |
|
Reconciliation of Income before Income Taxes to Non-GAAP Income before Income Taxes |
|||||
Income before income taxes, as reported |
$ |
37,076 |
$ |
19,472 |
|
Stock-based compensation |
4,590 |
4,916 |
|||
Amortization of acquisition intangibles |
1,081 |
844 |
|||
Non-GAAP income before income taxes |
$ |
42,747 |
$ |
25,232 |
|
Reconciliation of Provision for Income Taxes to Non-GAAP Provision For Income Taxes |
|||||
Provision for income taxes, as reported |
$ |
6,615 |
$ |
1,119 |
|
Stock-based compensation |
1,840 |
1,545 |
|||
Amortization of acquisition intangibles |
350 |
253 |
|||
Non-GAAP provision for income taxes |
$ |
8,805 |
$ |
2,917 |
|
Reconciliation of GAAP Net Income, Basic EPS and Diluted EPS to Non-GAAP Net Income, Basic EPS and Diluted EPS |
|||||
(unaudited) |
|||||
Three Months Ended |
|||||
March 31, |
|||||
2011 |
2010 |
||||
Net income, as reported |
$ |
30,461 |
$ |
18,353 |
|
Adjustments to reconcile net income to non-GAAP net income: |
|||||
Stock-based compensation, net of tax effect |
2,750 |
3,371 |
|||
Amortization of acquisition intangibles, net of tax effect |
731 |
591 |
|||
Non-GAAP net income |
$ |
33,942 |
$ |
22,315 |
|
Basic EPS, as reported |
$ |
0.26 |
$ |
0.16 |
|
Adjustment to reconcile basic EPS to non-GAAP |
|||||
basic EPS: |
|||||
Impact of stock-based compensation, net of tax effect |
$ |
0.02 |
$ |
0.03 |
|
Impact of amortization of acquisition intangibles, net of tax effect |
$ |
0.01 |
$ |
0.00 |
|
Non-GAAP basic EPS |
$ |
0.29 |
$ |
0.19 |
|
Diluted EPS, as reported |
$ |
0.25 |
$ |
0.16 |
|
Adjustment to reconcile diluted EPS to non-GAAP |
|||||
diluted EPS: |
|||||
Impact of stock-based compensation, net of tax effect |
$ |
0.02 |
$ |
0.03 |
|
Impact of amortization of acquisition intangibles, net of tax effect |
$ |
0.01 |
$ |
0.00 |
|
Non-GAAP diluted EPS |
$ |
0.28 |
$ |
0.19 |
|
Weighted average shares outstanding - |
|||||
Basic |
118,693 |
116,070 |
|||
Diluted |
120,443 |
117,652 |
|||
Reconciliation of Net Income and Diluted EPS to EBITDA and EBITDA Diluted EPS |
|||||
(unaudited) |
|||||
Three Months Ended |
|||||
March 31, |
|||||
2011 |
2010 |
||||
Net income, as reported |
$ |
30,461 |
$ |
18,353 |
|
Adjustments to reconcile net income to EBITDA: |
|||||
Interest income |
(341) |
(300) |
|||
Taxes |
6,615 |
1,119 |
|||
Depreciation and amortization |
10,973 |
9,442 |
|||
EBITDA |
$ |
47,708 |
$ |
28,614 |
|
Diluted EPS, as reported |
$ |
0.25 |
$ |
0.16 |
|
Adjustment to reconcile diluted EPS to EBITDA |
|||||
Interest income |
$ |
(0.00) |
$ |
(0.00) |
|
Taxes |
$ |
0.06 |
$ |
0.00 |
|
Depreciation and amortization |
$ |
0.09 |
$ |
0.08 |
|
EBITDA diluted EPS |
$ |
0.40 |
$ |
0.24 |
|
Weighted average shares outstanding - Diluted |
120,443 |
117,652 |
|||
National Instruments |
||||||
Reconciliation of GAAP to Non-GAAP EPS Guidance |
||||||
(unaudited) |
||||||
Three months ended |
||||||
June 30, 2011 |
||||||
Low |
High |
|||||
GAAP Fully Diluted EPS, guidance |
$ |
0.19 |
$ |
0.27 |
||
Adjustment to reconcile diluted EPS to non-GAAP |
||||||
diluted EPS: |
||||||
Impact of stock-based compensation, net of tax effect |
$ |
0.03 |
$ |
0.03 |
||
Impact of amortization of acquisition intangibles, net of tax effect |
$ |
0.01 |
$ |
0.01 |
||
Non-GAAP diluted EPS, guidance |
$ |
0.23 |
$ |
0.31 |
||
SOURCE National Instruments
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article